Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

Five years, one artist, one robot: how Maxim Gehricke made SEN, a 3D animated short film created solo from concept to final ...

New framework syncs robot lip movements with speech, supporting 11+ languages and enhancing humanlike interaction.

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008)7-year ...

As independent AI researcher Simon Willison wrote in a post distinguishing serious AI-assisted development from casual “ vibe ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutations Adolore's Kv7 voltage-gated ...

Prefoldin 5 stabilises neuronal microtubules and suppresses Tau-mediated neurotoxicity, offering a potential therapeutic target for tauopathies.

M0G Fireweed Metals Corp. is pleased to report the initial results of a major step-out drill hole at Tom South targeting ...